Skip to main content
Fig. 2 | Journal of Cardiothoracic Surgery

Fig. 2

From: Dexmedetomidine ameliorates diabetic cardiomyopathy by inhibiting ferroptosis through the Nrf2/GPX4 pathway

Fig. 2

DEX ameliorates HG-induced oxidative stress and ferroptosis of H9C2 cells. (A) Total SOD activity and MDA levels; (B) Fe2+ concentration; (C) ROS levels assessed by DCFH-DA. Three replicates were guaranteed in cell experiments. Mean ± standard deviation was introduced to represent data. The comparison among multiple groups was made using one-way analysis of variance with Tukey’s test. * p < 0.05, ** p < 0.01, *** p < 0.001

Back to article page